Redox regulation of the hypoxia-inducible factor

Biological Chemistry

Volumn 387, Issue 10-11, 2006, Pages 1337-1346

  Pouysségur, Jacques ^a   Mechta Grigoriou, Fatima ^b  

^a CENTRE ANTOINE LACASSAGNE   (France)

^b INSTITUT CURIE   (France)

Author keywords

Cancer; Hypoxia inducible factor (HIF); Metabolism; Oxygen sensing; Prolyl hydroxylase domain (PHD); ROS; Stress

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; REACTIVE OXYGEN METABOLITE;

CANCER; COMPARATIVE STUDY; CONFERENCE PAPER; CYTOSOL; HUMAN; HYPOXIA; MAMMAL; MITOCHONDRION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STABILITY; REGULATORY MECHANISM; SIGNAL PROCESSING; UPREGULATION;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CYTOSOL; HOMEOSTASIS; HUMANS; MITOCHONDRIA; OXIDATION-REDUCTION; OXYGEN;

MAMMALIA;

EID: 33750622643     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2006.167     Document Type: Conference Paper

References (138)

1. Aebersold, D.M., Burri, P., Beer, K.T., Laissue, J., Djonov, V., Greiner, R.H., and Semenza, G.L. (2001). Expression of hypoxia-inducible factor-1α: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res. 61, 2911-2916.
2. Agani, F.H., Pichiule, P., Chavez, J.C., and LaManna, J.C. (2000). The role of mitochondria in the regulation of hypoxia-inducible factor 1 expression during hypoxia. J. Biol. Chem. 275, 35863-35867.
3. Agani, P.H., Puchowicz, M., Chavez, J.C., Pichiule, P., and LaManna, J. (2002). Role of nitric oxide in the regulation of HIF-1α expression during hypoxia. Am. J. Physiol. Cell Physiol. 283, C178-C186.
4. Akeno, N., Robins, J., Zhang, M., Czyzyk-Krzeska, M.F., and Clemens, T.L. (2002). Induction of vascular endothelial growth factor by IGF-I in osteoblast-like cells is mediated by the PI3K signaling pathway through the hypoxia-inducible factor-2α. Endocrinology 143, 420-425.
5. Appelhoff, R.J., Tian, Y.M., Raval, R.R., Turley, H., Harris, A.L., Pugh, C.W., Ratcliffe, P.J., and Gleadle, J.M. (2004). Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J. Biol. Chem. 279, 38458-38465.
6. Aprelikova, O., Chandramouli, G.V., Wood, M., Vasselli, J.R., Riss, J., Maranchie, J.K., Linehan, W.M., and Barrett, J.C. (2004). Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors. J. Cell Biochem. 92, 491-501.
7. Arbiser, J.L., Petros, J., Klafter, R., Govindajaran, B., McLaughlin, E.R., Brown, L.F., Cohen, C., Moses, M., Kilroy, S., Arnold, R.S., and Lambeth, J.D. (2002). Reactive oxygen generated by Nox1 triggers the angiogenic switch. Proc. Natl. Acad. Sci. USA 99, 715-720.
8. Babior, B.M. (2004). NADPH oxidase. Curr. Opin. Immunol. 16, 42-47.
9. Berra, E., Benizri, E., Ginouves, A., Volmat, V., Roux, D., and Pouyssegur, J. (2003). HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia. EMBO J. 22, 4082-4090.
10. Blancher, C., Moore, J.W., Robertson, N., and Harris, A.L. (2001). Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1α, HIF-2α, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3′-kinase/Akt signaling pathway. Cancer Res. 61, 7349-7355.
11. Bokoch, G.M. and Knaus, U.G. (2003). NADPH oxidases: not just for leukocytes anymore! Trends Biochem. Sci. 28, 502-508.
12. 2 are potent inducers of vascular endothelial growth factor expression in cultured keratinocytes. J. Biol. Chem. 271, 21793-21797.
13. Bruick, R.K. and McKnight, S.L. (2001). A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294, 1337-1340.
14. Brunelle, J.K., Bell, E.L., Quesada, N.M., Vercauteren, K., Tiranti, V., Zeviani, M., Scarpulla, R.C., and Chandel, N.S. (2005). Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab. 1, 409-414.
15. Callapina, M., Zhou, J., Schnitzer, S., Metzen, E., Lohr, C., Deitmer, J.W., and Brune, B. (2005). Nitric oxide reverses desferrioxamine- and hypoxia-evoked HIF-1α accumulation - implications for prolyl hydroxylase activity and iron. Exp. Cell Res. 306, 274-284.
16. Chan, D.A., Sutphin, P.D., Denko, N.C., and Giaccia, A.J. (2002). Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1α. J. Biol. Chem. 277, 40112-40117.
17. Chandel, N.S., Maltepe, E., Goldwasser, E., Mathieu, C.E., Simon, M.C., and Schumacker, P.T. (1998). Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl. Acad. Sci. USA 95, 11715-11720.
18. 2 sensing. J. Biol. Chem. 275, 25130-25138.
19. del Peso, L., Castellanos, M.C., Temes, E., Martin-Puig, S., Cuevas, Y., Olmos, G., and Landazuri, M.O. (2003). The von Hippel Lindau/hypoxia-inducible factor (HIF) pathway regulates the transcription of the HIF-proline hydroxylase genes in response to low oxygen. J. Biol. Chem. 278, 48690-48695.
20. Doege, K., Heine, S., Jensen, I., Jelkmann, W., and Metzen, E. (2005). Inhibition of mitochondrial respiration elevates oxygen concentration but leaves regulation of hypoxia-inducible factor (HIF) intact. Blood 106, 2311-2317.
21. Duyndam, M.C., Hulscher, T.M., Fontijn, D., Pinedo, H.M., and Boven, E. (2001). Induction of vascular endothelial growth factor expression and hypoxia-inducible factor 1α protein by the oxidative stressor arsenite. J. Biol. Chem. 276, 48066-48076.
22. Emerling, B.M., Platanias, L.C., Black, E., Nebreda, A.R., Davis, R.J., and Chandel, N.S. (2005). Mitochondrial reactive oxygen species activation of p38 mitogen-activated protein kinase is required for hypoxia signaling. Mol. Cell. Biol. 25, 4853-4862.
23. Enomoto, N., Koshikawa, N., Gassmann, M., Hayashi, J,. and Takenaga, K. (2002). Hypoxic induction of hypoxia-inducible factor-1α and oxygen-regulated gene expression in mitochondrial DNA-depleted HeLa cells. Biochem. Biophys. Res. Commun. 297, 346-352.
24. Epstein, A.C., Gleadle, J.M., McNeill, L.A., Hewitson, K.S., O'Rourke, J., Mole, D.R., Mukherji, M., Metzen, E., Wilson, M.I., Dhanda, A., et al. (2001). C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107, 43-54.
25. Fandrey, J., Frede, S., and Jelkmann, W. (1994). Role of hydrogen peroxide in hypoxia-induced erythropoietin production. Biochem. J. 303, 507-510.
26. Fukuda, R., Hirota, K., Fan, F., Jung, Y.D., Ellis, L.M., and Semenza, G.L. (2002). Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J. Biol. Chem. 277, 38205-38211.
27. Gao, N., Ding, M., Zheng, J.Z., Zhang, Z., Leonard, S.S., Liu, K.J., Shi, X., and Jiang, B.H. (2002a). Vanadate-induced expression of hypoxia-inducible factor 1α and vascular endothelial growth factor through phosphatidylinositol 3-kinase/Akt pathway and reactive oxygen species. J. Biol. Chem. 277, 31963-31971.
28. Gao, N., Jiang, B.H., Leonard, S.S., Corum, L., Zhang, Z., Roberts, J.R., Antonini, J., Zheng, J.Z., Flynn, D.C., Castranova, V., and Shi, X. (2002b). p38 signaling-mediated hypoxia-inducible factor 1α and vascular endothelial growth factor induction by Cr(VI) in DU145 human prostate carcinoma cells. J. Biol. Chem. 277, 45041-45048.
29. Gao, N., Shen, L., Zhang, Z., Leonard, S.S., He, H., Zhang, X.G., Shi, X., and Jiang, B.H. (2004). Arsenite induces HIF-1α and VEGF through PI3K, Akt and reactive oxygen species in DU145 human prostate carcinoma cells. Mol. Cell. Biochem. 255, 33-45.
30. Gerald, D., Berra, E., Frapart, Y.M., Chan, D.A., Giaccia, A.J., Mansuy, D., Pouyssegur, J., Yaniv, M., and Mechta-Grigoriou, F. (2004). JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 118, 781-794.
31. Giaccia, A., Siim, B.G., and Johnson, R.S. (2003). HIF-1 as a target for drug development. Nat. Rev. Drug Discov. 2, 803-811.
32. Gorlach, A., Diebold, I., Schini-Kerth, V.B., Berchner-Pfannschmidt, U., Roth, U., Brandes, R.P., Kietzmann, T., and Busse, R. (2001). Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: role of the p22(phox)-containing NADPH oxidase. Circ. Res. 89, 47-54.
33. Goyal, P., Weissmann, N., Grimminger, F., Hegel, C., Bader, L., Rose, F., Fink, L., Ghofrani, H.A., Schermuly, R.T., Schmidt, H.H., Seeger, W., and Hanze, J. (2004). Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxia-inducible factor 1 via increase in reactive oxygen species. Free Radic. Biol. Med. 36, 1279-1288.
34. Grugel, S., Finkenzeller, G., Weindel, K., Barleon, B., and Marme, D. (1995). Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. J. Biol. Chem. 270, 25915-25919.
35. Guzy, R.D., Hoyos, B., Robin, E., Chen, H., Liu, L., Mansfield, K.D., Simon, M.C., Hammerling, U., and Schumacker, P.T. (2005). Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 1, 401-408.
36. Haddad, J.J. and Land, S.C. (2001). A non-hypoxic, ROS-sensitive pathway mediates TNF-α-dependent regulation of HIF-1α. FEBS Lett. 505, 269-274.
37. Hagen, T., Taylor, C.T., Lam, F., and Moncada, S. (2003). Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1α. Science 302, 1975-1978.
38. Hellwig-Burgel, T., Rutkowski, K., Metzen, E., Fandrey, J., and Jelkmann, W. (1999). Interleukin-1β and tumor necrosis factor-α stimulate DNA binding of hypoxia-inducible factor-1. Blood 94, 1561-1567.
39. Hewitson, K.S., McNeill, L.A., Riordan, M.V., Tian, Y.M., Bullock, A.N., Welford, R.W., Elkins, J.M., Oldham, N.J., Bhattacharya, S., Gleadle, J.M., et al. (2002). Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J. Biol. Chem. 277, 26351-26355.
40. Hirota, K. and Semenza, G.L. (2001). Rac1 activity is required for the activation of hypoxia-inducible factor 1. J. Biol. Chem. 276, 21166-21172.
41. Hirsila, M., Koivunen, P., Gunzler, V., Kivirikko, K.I., and Myllyharju, J. (2003). Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J. Biol. Chem. 278, 30772-30780.
42. Hirsila, M., Koivunen, P., Xu, L., Seeley, T., Kivirikko, K.I., and Myllyharju, J. (2005). Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathway. FASEB J. 19, 1308-1310.
43. Ho, V.T. and Bunn, H.F. (1996). Effects of transition metals on the expression of the erythropoietin gene: further evidence that the oxygen sensor is a heme protein. Biochem. Biophys. Res. Commun. 223, 175-180.
44. Hon, W.C., Wilson, M.I., Harlos, K., Claridge, T.D., Schofield, C.J., Pugh, C.W., Maxwell, P.H., Ratcliffe, P.J., Stuart, D.I., and Jones, E.Y. (2002). Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL. Nature 417, 975-978.
45. Hu, C.J., Iyer, S., Sataur, A., Covello, K.L., Chodosh, L.A., and Simon, M.C. (2006). Differential regulation of the transcriptional activities of hypoxia-inducible factor 1 alpha (HIF-1α) and HIF-2α in stem cells. Mol. Cell. Biol. 26, 3514-3526.
46. Hu, C.J., Wang, L.Y., Chodosh, L.A., Keith, B., and Simon, M.C. (2003). Differential roles of hypoxia-inducible factor 1α (HIF-1α) and HIF-2α in hypoxic gene regulation. Mol. Cell. Biol. 23, 9361-9374.
47. Irani, K., Xia, Y., Zweier, J.L., Sollott, S.J., Der, C.J., Fearon, E.R., Sundaresan, M., Finkel, T., and Goldschmidt-Clermont, P.J. (1997). Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science 275, 1649-1652.
48. Ivan, M., Haberberger, T., Gervasi, D.C., Michelson, K.S., Gunzler, V., Kondo, K., Yang, H., Sorokina, I., Conaway, R.C., Conaway, J.W., and Kaelin, W.G. Jr. (2002). Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc. Natl. Acad. Sci. USA 99, 13459-13464.
49. 2 sensing. Science 292, 464-468.
50. 2-regulated prolyl hydroxylation. Science 292, 468-472.
51. Jiang, B.H., Jiang, G., Zheng, J.Z., Lu, Z., Hunter, T., and Vogt, P.K. (2001). Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ. 12, 363-369.
52. Kaelin, W., Maher, E., Richard, S., and Maxwell, P.H. (1999). The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Cancer Res. 59, 2251-2253.
53. Kietzmann, T., Jungermann, K., and Gorlach, A. (2003a). Regulation of the hypoxia-dependent plasminogen activator inhibitor 1 expression by MAP kinases. Thromb. Haemost. 89, 666-673.
54. Kietzmann, T., Samoylenko, A., Roth, U., and Jungermann, K. (2003b). Hypoxia-inducible factor-1 and hypoxia response elements mediate the induction of plasminogen activator inhibitor-1 gene expression by insulin in primary rat hepatocytes. Blood 101, 907-914.
55. Kim, W. and Kaelin, W.G. Jr. (2003). The von Hippel-Lindau tumor suppressor protein: new insights into oxygen sensing and cancer. Curr. Opin. Genet. Dev. 13, 55-60.
56. Knowles, H.J., Mole, D.R., Ratcliffe, P.J., and Harris, A.L. (2006). Normoxic stabilization of hypoxia-inducible factor-1α by modulation of the labile iron pool in differentiating U937 macrophages: effect of natural resistance-associated macrophage protein 1. Cancer Res. 66, 2600-2607.
57. Knowles, H.J., Raval, R.R., Harris, A.L., and Ratcliffe, P.J. (2003). Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells. Cancer Res. 63, 1764-1768.
58. Kohl, R., Zhou, J., and Brune, B. (2006). Reactive oxygen species attenuate nitric-oxide-mediated hypoxia-inducible factor-1α stabilization. Free Radic. Biol. Med. 40, 1430-1442.
59. Kozhukhar, A.V., Yasinska, I.M., and Sumbayev, V.V. (2006). Nitric oxide inhibits HIF-1α protein accumulation under hypoxic conditions: implication of 2-oxoglutarate and iron. Biochimie 88, 411-418.
60. Lambeth, J.D. (2004). NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4, 181-189.
61. Lando, D., Peet, D.J., Gorman, J.J., Whelan, D.A., Whitelaw, M.L., and Bruick, R.K. (2002a). FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 16, 1466-1471.
62. Lando, D., Peet, D.J., Whelan, D.A., Gorman, J.J., and Whitelaw, M.L. (2002b). Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 295, 858-861.
63. Larcher, F., Robles, A.I., Duran, H., Murillas, R., Quintanilla, M., Cano, A., Conti, C.J., and Jorcano, J.L. (1996). Up-regulation of vascular endothelial growth factor/vascular permeability factor in mouse skin carcinogenesis correlates with malignant progression state and activated H-ras expression levels. Cancer Res. 56, 5391-5396.
64. Laughner, E., Taghavi, P., Chiles, K., Mahon, P.C., and Semenza, G.L. (2001). HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1α (HIF-1α) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell. Biol. 21, 3995-4004.
65. Lee, K.S., Kim, S.R., Park, S.J., Park, H.S., Min, K.H., Lee, M.H., Jin, S.M., Jin, G.Y., Yoo, W.H., and Lee, Y.C. (2006). Hydrogen peroxide induces vascular permeability via regulation of vascular endothelial growth factor. Am. J. Respir. Cell Mol. Biol. 35, 190-197.
66. Li, Q., Chen, H., Huang, X., and Costa, M. (2006). Effects of 12 metal ions on iron regulatory protein 1 (IRP-1) and hypoxia-inducible factor-1α (HIF-1α) and HIF-regulated genes. Toxicol. Appl. Pharmacol. 213, 245-255.
67. Lu, H., Dalgard, C.L., Mohyeldin, A., McFate, T., Tait, A.S., and Verma, A. (2005). Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1. J. Biol. Chem. 280, 41928-41939.
68. Mahon, P.C., Hirota, K., and Semenza, G.L. (2001). FIH-1: a novel protein that interacts with HIF-1α and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 15, 2675-2686.
69. Makino, Y., Cao, R., Svensson, K., Bertilsson, G., Asman, M., Tanaka, H., Cao, Y., Berkenstam, A., and Poellinger, L. (2001). Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression. Nature 414, 550-554.
70. Makino, Y., Kanopka, A., Wilson, W.J., Tanaka, H., and Poellinger, L. (2002). Inhibitory PAS domain protein (IPAS) is a hypoxia-inducible splicing variant of the hypoxia-inducible factor-3a locus. J. Biol. Chem. 277, 32405-32408.
71. Mansfield, K.D., Guzy, R.D., Pan, Y., Young, R.M., Cash, T.P., Schumacker, P.T., and Simon, M.C. (2005). Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-α activation. Cell Metab. 1, 393-399.
72. Maranchie, J.K. and Zhan, Y. (2005). Nox4 is critical for hypoxia-inducible factor 2-α transcriptional activity in von Hippel-Lindau-deficient renal cell carcinoma. Cancer Res. 65, 9190-9193.
73. Marxsen, J.H., Stengel, P., Doege, K., Heikkinen, P., Jokilehto, T., Wagner, T., Jelkmann, W., Jaakkola, P., and Metzen, E. (2004). Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-α-prolyl-4- hydroxylases. Biochem. J. 381, 761-767.
74. Maxwell, P.H. (2005). The HIF pathway in cancer. Semin. Cell Dev. Biol. 16, 523-530.
75. Maxwell, P.H., Dachs, G.U., Gleadle, J.M., Nicholls, L.G., Harris, A.L., Stratford, I.J., Hankinson, O., Pugh, C.W., and Ratcliffe, P.J. (1997). Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl. Acad. Sci. USA 94, 8104-8109.
76. Maxwell, P.H., Wiesener, M.S., Chang, G.W., Clifford, S.C., Vaux, E.C., Cockman, M.E., Wykoff, C.C., Pugh, C.W., Maher, E.R., and Ratcliffe, P.J. (1999). The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399, 271-275.
77. Mayer, A., Wree, A., Hockel, M., Leo, C., Pilch, H., and Vaupel, P. (2004). Lack of correlation between expression of HIF-1α protein and oxygenation status in identical tissue areas of squamous cell carcinomas of the uterine cervix. Cancer Res. 64, 5876-5881.
78. Mazure, N.M., Chen, E.Y., Yeh, P., Laderoute, K.R., and Giaccia, A.J. (1996). Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression. Cancer Res. 56, 3436-3440.
79. McNeill, L.A., Hewitson, K.S., Claridge, T.D., Seibel, J.F., Horsfall, L.E., and Schofield, C.J. (2002). Hypoxia-inducible factor asparaginyl hydroxylase (FIH-1) catalyses hydroxylation at the β-carbon of asparagine-803. Biochem. J. 367, 571-575.
80. Melillo, G., Taylor, L.S., Brooks, A., Musso, T., Cox, G.W., and Varesio, L. (1997). Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine. J. Biol. Chem. 272, 12236-12243.
81. Metzen, E., Berchner-Pfannschmidt, U., Stengel, P., Marxsen, J.H., Stolze, I., Klinger, M., Huang, W.Q., Wotzlaw, C., Hellwig-Burgel, T., Jelkmann, W., et al. (2003). Intracellular localisation of human HIF-1α hydroxylases: implications for oxygen sensing. J. Cell Sci. 116, 1319-1326.
82. Metzen, E., Stiehl, D.P., Doege, K., Marxsen, J.H., Hellwig-Burgel, T., and Jelkmann, W. (2005). Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln-1) gene: identification of a functional hypoxia-responsive element. Biochem. J. 387, 711-717.
83. Min, J.-H., Yang, H., Ivan, M., Gertler, F., Kaelin, W.G., and Pavletich, N.P. (2002). Structure of HIF1a-pVHL complex: hydroxyproline recognition in signaling. Science 296, 1886-1889.
84. Moeller, B.J., Cao, Y., Li, C.Y., and Dewhirst, M.W. (2004). Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules. Cancer Cell 5, 429-441.
85. Muller, F.L., Liu, Y., and Van Remmen, H. (2004). Complex III releases superoxide to both sides of the inner mitochondrial membrane. J. Biol. Chem. 279, 49064-49073.
86. Ohh, M. (2000). Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel-Lindau protein. Oncologist 5 (Suppl. 1), 32-36.
87. Papandreou, I., Cairns, R.A., Fontana, L., Lim, A.L., and Denko, N.C. (2006). HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 3, 187-197.
88. Park, J.H., Kim, T.Y., Jong, H.S., Chun, Y.S., Park, J.W., Lee, C.T., Jung, H.C., Kim, N.K., and Bang, Y.J. (2003). Gastric epithelial reactive oxygen species prevent normoxic degradation of hypoxia-inducible factor-1α in gastric cancer cells. Clin. Cancer Res. 9, 433-440.
89. Pescador, N., Cuevas, Y., Naranjo, S., Alcaide, M., Villar, D., Landazuri, M.O., and Del Peso, L. (2005). Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene. Biochem. J. 390, 189-197.
90. Pollard, P.J., Briere, J.J., Alam, N.A., Barwell, J., Barclay, E., Wortham, N.C., Hunt, T., Mitchell, M., Olpin, S., Moat, S.J., et al. (2005). Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations. Hum. Mol. Genet. 14, 2231-2239.
91. Postovit, L.M., Sullivan, R., Adams, M.A., and Graham, C.H. (2005). Nitric oxide signalling and cellular adaptations to changes in oxygenation. Toxicology 208, 235-248.
92. Pouyssegur, J., Dayan, F., and Mazure, N.M. (2006). Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441, 437-443.
93. Pugh, C.W. and Ratcliffe, P.J. (2003a). Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9, 677-684.
94. Pugh, C.W. and Ratcliffe, P.J. (2003b). The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis. Semin. Cancer Biol. 13, 83-89.
95. Qian, D., Lin, H.Y., Wang, H.M., Zhang, X., Liu, D.L., Li, Q.L., and Zhu, C. (2004). Normoxic induction of the hypoxic-inducible factor-1α by interleukin-1β involves the extracellular signal-regulated kinase 1/2 pathway in normal human cytotrophoblast cells. Biol. Reprod. 70, 1822-1827.
96. Quintero, M., Brennan, P.A., Thomas, G.J., and Moncada, S. (2006). Nitric oxide is a factor in the stabilization of hypoxia-inducible factor-1α in cancer: role of free radical formation. Cancer Res. 66, 770-774.
97. Rak, J., Mitsuhashi, Y., Bayko, L., Filmus, J., Shirasawa, S., Sasazuki, T., and Kerbel, R.S. (1995). Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res. 55, 4575-4580.
98. Richard, D.E., Berra, E., and Pouyssegur, J. (2000). Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1α in vascular smooth muscle cells. J. Biol. Chem. 275, 26765-26771.
99. Rodriguez, J.A., Nespereira, B., Perez-Ilzarbe, M., Eguinoa, E., and Paramo, J.A. (2005). Vitamins C and E prevent endothelial VEGF and VEGFR-2 overexpression induced by porcine hypercholesterolemic LDL. Cardiovasc. Res. 65, 665-673.
100. Roth, U., Curth, K., Unterman, T.G., and Kietzmann, T. (2004). The transcription factors HIF-1 and HNF-4 and the coactivator p300 are involved in insulin-regulated glucokinase gene expression via the phosphatidylinositol 3-kinase/protein kinase B pathway. J. Biol. Chem. 279, 2623-2631.
101. Sanchez-Lopez, E., Lopez, A.F., Esteban, V., Yague, S., Egido, J., Ruiz-Ortega, M., and Alvarez-Arroyo, M.V. (2005). Angiotensin II regulates vascular endothelial growth factor via hypoxia-inducible factor-1α induction and redox mechanisms in the kidney. Antioxid. Redox Signal. 7, 1275-1284.
102. Sanjuan-Pla, A., Cervera, A.M., Apostolova, N., Garcia-Bou, R., Victor, V.M., Murphy, M.P., and McCreath, K.J. (2005). A targeted antioxidant reveals the importance of mitochondrial reactive oxygen species in the hypoxic signaling of HIF-1α. FEBS Lett. 579, 2669-2674.
103. Schofield, C.J. and Ratcliffe, P.J. (2004). Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 5, 343-354.
104. Schofield, C.J. and Zhang, Z. (1999). Structural and mechanistic studies on 2-oxoglutarate-dependent oxygenases and related enzymes. Curr. Opin. Struct. Biol. 9, 722-731.
105. Schroedl, C., McClintock, D.S., Budinger, G.R., and Chandel, N.S. (2002). Hypoxic but not anoxic stabilization of HIF-1α requires mitochondrial reactive oxygen species. Am. J. Physiol. Lung Cell Mol. Physiol. 283, L922-L931.
106. Selak, M.A., Armour, S.M., MacKenzie, E.D., Boulahbel, H., Watson, D.G., Mansfield, K.D., Pan, Y., Simon, M.C., Thompson, C.B., and Gottlieb, E. (2005). Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase. Cancer Cell 7, 77-85.
107. Selak, M.A., Duran, R.V., and Gottlieb, E. (2006). Redox stress is not essential for the pseudo-hypoxic phenotype of succinate dehydrogenase deficient cells. Biochim. Biophys. Acta 1757, 567-572.
108. 2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol. 15, 551-578.
109. Semenza, G.L. (2003). Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3, 721-732.
110. Semenza, G.L., Roth, P.H., Fang, H.M., and Wang, G.L. (1994). Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269, 23757-23763.
111. Shatrov, V.A., Sumbayev, V.V., Zhou, J., and Brune, B. (2003). Oxidized low-density lipoprotein (oxLDL) triggers hypoxia-inducible factor-1α (HIF-1α) accumulation via redox-dependent mechanisms. Blood 101, 4847-4849.
112. Shi, Y.H., Wang, Y.X., Bingle, L., Gong, L.H., Heng, W.J., Li, Y., and Fang, W.G. (2005). In vitro study of HIF-1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: involvement of PI-3K/Akt and MEK1/ERK pathways. J. Pathol. 205, 530-536.
113. Sodhi, A., Montaner, S., Miyazaki, H., and Gutkind, J.S. (2001). MARK and Akt act cooperatively but independently on hypoxia inducible factor-1α in rasV12 upregulation of VEGF. Biochem. Biophys. Res. Commun. 287, 292-300.
114. Sowter, H.M., Raval, R.R., Moore, J.W., Ratcliffe, P.J., and Harris, A.L. (2003). Predominant role of hypoxia-inducible transcription factor (Hif)-1α versus Hif-2α in regulation of the transcriptional response to hypoxia. Cancer Res. 63, 6130-6134.
115. Srinivas, V., Leshchinsky, I., Sang, N., King, M.P., Minchenko, A., and Caro, J. (2001). Oxygen sensing and HIF-1 activation does not require an active mitochondrial respiratory chain electron-transfer pathway. J. Biol. Chem. 276, 21995-21998.
116. Stiehl, D.P., Jelkmann, W., Wenger, R.H., and Hellwig-Burgel, T. (2002). Normoxic induction of the hypoxia-inducible factor 1α by insulin and interleukin-1β involves the phosphatidylinositol 3-kinase pathway. FEBS Lett. 512, 157-162.
117. Stiehl, D.P., Wirthner, R., Koditz, J., Spielmann, P., Camenisch, G., and Wenger, R.H. (2006). Increased prolyl-4-hydroxylase domain (PHD) proteins compensate for decreased oxygen levels: evidence for an autoregulatory oxygen-sensing system. J. Biol. Chem. 281, 23482-23491.
118. Tacchini, L., Dansi, P., Matteucci, E., and Desiderio, M.A. (2001). Hepatocyte growth factor signalling stimulates hypoxia inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells. Carcinogenesis 22, 1363-1371.
119. Taylor, M.S. (2001). Characterization and comparative analysis of the EGLN gene family. Gene 275, 125-132.
120. Thomas, D.D., Ridnour, L.A., Espey, M.G., Donzelli, S., Ambs, S., Hussain, S.P., Harris, C.C., Degraff, W., Roberts, D.D., Mitchell, J.B., and Wink, D.A. (2006). Superoxide fluxes limit nitric oxide-induced signaling. J. Biol. Chem., Epub ahead of print, doi: 10.1074/jbc.M602242200.
121. Tian, H., McKnight, S.L., and Russell, D.W. (1997). Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev. 11, 72-82.
122. Treins, C., Giorgetti-Peraldi, S., Murdaca, J., Semenza, G.L., and Van Obberghen, E. (2002). Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J. Biol. Chem. 277, 27975-27981.
123. Vaupel, P. (2004). The role of hypoxia-induced factors in tumor progression. Oncologist 9 (Suppl. 5), 10-17.
124. Vaux, E.C., Metzen, E., Yeates, K.M., and Ratcliffe, P.J. (2001). Regulation of hypoxia-inducible factor is preserved in the absence of a functioning mitochondrial respiratory chain. Blood 98, 296-302.
125. Verma, A. (2006). Oxygen-sensing in tumors. Curr. Opin. Clin. Nutr. Metab. Care 9, 366-378.
126. Wang, D., Na, X., Schoen, S.R., Messing, E.M., Wu, G., and Hon, W.C. (2002). Structural basis for the recognition of hydroxyproline in HIF-1 α by pVHL. Biochem. Biophys. Res. Commun. 294, 700-709.
127. Wang, G.L., Jiang, B.H., and Semenza, G.L. (1995). Effect of protein kinase and phosphatase inhibitors on expression of hypoxia-inducible factor 1. Biochem. Biophys. Res. Commun. 216, 669-675.
128. Wang, G.L. and Semenza, G.L. (1993). Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82, 3610-3615.
129. 2-regulated gene expression. FASEB J. 16, 1151-1162.
130. Wenger, R.H., Stiehl, D.P., and Camenisch, G. (2005). Integration of oxygen signaling at the consensus HRE. Sci. STKE 2005, 306: re12.
131. White, F.C., Benehacene, A., Scheele, J.S., and Kamps, M. (1997). VEGF mRNA is stabilized by ras and tyrosine kinase oncogenes, as well as by UV radiation-evidence for divergent stabilization pathways. Growth Factors 14, 199-212.
132. Wiesener, M.S., Turley, H., Allen, W.E., Willam, C., Eckardt, K.U., Talks, K.L., Wood, S.M., Gatter, K.C., Harris, A.L., Pugh, C.W., et al. (1998). Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1α. Blood 92, 2260-2268.
133. Yu, F., White, S.B., Zhao, Q., and Lee F.S. (2001). HIR-1α binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc. Natl. Acad. Sci. USA 98, 9630-9635.
134. Zelzer, E., Levy, Y., Kahana, C., Shilo, B.Z., Rubinstein, M., and Cohen, B. (1998). Insulin induces transcription of target genes through the hypoxia-inducible factor HIR-1α/ARNT. EMBO J. 17, 5085-5094.
135. Zhou, J., Fandrey, J., Schumann, J., Tiegs, G., and Brune, B. (2003). NO and TNR-α released from activated macrophages stabilize HIR-1α in resting tubular LLC-PK1 cells. Am. J. Physiol. Cell Physiol. 284, C439-C446.
136. Zhou, J., Schmid, T., and Brune, B. (2004). HIR-1α and p53 as targets of NO in affecting cell proliferation, death and adaptation. Curr. Mol. Med. 4, 741-751.
137. Zhu, X.Y., Rodriguez-Porcel, M., Bentley, M.D., Chade, A.R., Sica, V., Napoli, C., Caplice, N., Ritman, E.L., Lerman, A., and Lerman, L.O. (2004). Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia. Circulation 109, 2109-2115.
138. Zundel, W., Schindler, C., Haas-Kogan, D., Koong, A., Kaper, F., Chen, E., Gottschalk, A.R., Ryan, H.E., Johnson, R.S., Jefferson, A.B., et al. (2000). Loss of PTEN facilitates HIR-1-mediated gene expression. Genes Dev. 14, 391-396.